Validation of brief symptom indexes among patients with recurrent or metastatic squamous cell carcinoma of the head and neck: A trial of the ECOG-ACRIN Cancer Research Group (E1302).
Laura B OswaldJu-Whei LeeAthanassios ArgirisKimberly A WebsterArlene A ForastiereDavid CellaPublished in: Cancer medicine (2020)
There is initial evidence of validity for the FHNSI-10 and FHNSI-7 indexes and selected individual symptom endpoints as brief disease-related symptom assessments for patients with recurrent or metastatic SCCHN.